CD79A and non-small cell lung carcinoma: The current study investigated whether KLTi in combination with chemotherapy influences the percentage of peripheral blood T lymphocyte subsets (CD3+, CD4+, CD8+ and CD4+/CD8+) and peripheral blood immunoglobulins (IgA, IgG and IgM) in patients with advanced NSCLC.